Skip to main content
TH

TeleRare Health

Allay Health offers virtual care for patients with rare and genomic diseases, providing access to diagnostics, treatments, and specialists. The platform connects patients with empathetic and collaborative virtual care, leveraging technology to improve outcomes for those impacted by rare and genomic conditions.

Eagan, United StatesFounded 20234500+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Patients with rare and genomic diseases often face significant delays in diagnosis, limited access to specialists, and challenges in coordinating care, leading to increased morbidity and reduced quality of life. Traditional genetics clinics often have months- or years-long waiting lists, hindering timely access to necessary diagnostics and treatments.

Solution

TeleRare Health provides virtual care services to accelerate diagnosis and improve access to specialized care for individuals and families affected by rare and genetic diseases. The platform connects patients with geneticists and other specialists via telehealth, shortening the diagnostic odyssey from years to weeks. TeleRare Health offers a range of services, including genetic risk assessment, coordination and evaluation of genetic testing (including exome and genome sequencing), interpretation of prior genetic testing, and ongoing care with symptom management. The company also provides information on available therapies and clinical trials, as well as connections to patient advocacy organizations and support communities.

Target Audience

TeleRare Health serves individuals and families affected by rare and genetic diseases, as well as healthcare providers seeking to refer patients for genetic risk assessment, diagnosis, and management of known or suspected rare or genetic conditions.

Features

  • Fast and convenient video visits with geneticists and other rare disease specialists
  • Coordination and evaluation of genetic testing, including exome and genome sequencing
  • Interpretation and assessment of prior genetic testing results
  • Information on available FDA-approved therapies and clinical trials
  • Referrals to knowledgeable specialty care, regardless of geographic location, using the EnCompass® database
  • Connections to patient advocacy organizations and support communities
  • Continuous surveillance for new clinical trials, available medications, and reanalysis of genetic variants
This profile is AI-generated and may contain inaccuracies.